HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Diketo acids such as L-731,988 are potent inhibitors of HIV-1 integrase that inhibit integration and viral replication in cells. These compounds exhibit the unique ability to inhibit the strand transfer activity of integrase in the absence of an effect on 3′ end processing. To understand the reasons for this distinct inhibitory profile, we developed a scintillation proximity assay that permits analysis of radiolabeled inhibitor binding and integrase function. High-affinity binding of L-731,988 is shown to require the assembly of a specific complex on the HIV-1 long terminal repeat. The interaction of L-731,988 with the complex and the efficacy of L-731,988 in strand transfer can be abrogated by the interaction with target substrates, suggesting competition between the inhibitor and the target DNA. The L-731,988 binding site and that of the target substrate are thus distinct from that of the donor substrate and are defined by a conformation of integrase that is only adopted after assembly with the viral end. These results elucidate the basis for diketo acid inhibition of strand transfer and have implications for integrase-directed HIV-1 drug discovery efforts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These compounds bind to the IN active site only when it is engaged with vDNA and compete with target DNA157.”
From Structure and function of retroviral integrase (2022) · cites this paper as [157]
Citations
Cites
Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells
Hazuda, D. J., Felock, P., Witmer, M., Wolfe, A., Stillmock, K., Grobler, J. A., Espeseth, A., Gabryelski, L., Schleif, W., Blau, C., et al. (2000) · Science · doi:10.1126/science.287.5453.646 · Cited by 1,131
Self-citationKulkosky, J., Jones, K. S., Katz, R. A., Mack, J. P., & Skalka, A. M. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.5.2331 · Cited by 571
Engelman, A., & Craigie, R. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6361-6369.1992 · Cited by 519
Goldgur, Y., Craigie, R., Cohen, G. H., Fujiwara, T., Yoshinaga, T., Fujishita, T., Sugimoto, H., Endo, T., Murai, H., & Davies, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13040 · Cited by 496
Bushman, F. D., & Craigie, R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1339 · Cited by 410
Reversal of Integration and DNA Splicing Mediated by Integrase of Human Immunodeficiency Virus
Chow, S. A., Vincent, K. A., Ellison, V., & Brown, P. O. (1992) · Science · doi:10.1126/science.1738845 · Cited by 379
Engelman, A., Bushman, F. D., & Craigie, R. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05996.x · Cited by 350
Katz, R. A., Merkel, G., Kulkosky, J., Leis, J., & Skalka, A. M. (1990) · Cell · doi:10.1016/0092-8674(90)90290-u · Cited by 346
Sherman, P. A., & Fyfe, J. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5119 · Cited by 334
Wiskerchen, M., & Muesing, M. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.376-386.1995 · Cited by 273
Research works printed but not linked: 2
- J Kulkosky, K S Jones, R A Katz, J P Mack, A M Skalka Mol Cell Biol 12, 2331–2338 (1992).
- D Hazuda, P J Felock, J C Hastings, B Pramanik, A L Wolfe Drug Des Discov 15, 17–24 (1997).
Cited by
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
“For example, the HIV1 integrase inhibitor raltegravir was only discovered after several MMOAs had been investigated using different assay format”
BackgroundA review on recent developments of indole-containing antiviral agents
Zhang, M.-Z., Chen, Q., & Yang, G.-F. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.065 · Cited by 887
“21) [82, 83] .”
HIV-1 Antiretroviral Drug Therapy
Arts, E. J., & Hazuda, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007161 · Cited by 851
“All integrase inhibitors in development target the strand transfer reaction and are thus referred to as either INIs or more specifically, integrase strand transfer inhibitors (InSTIs) (Espeseth et al. 2000; Hazuda et al. 2004a,b; McColl and Chen 2010).”
BackgroundSelf-citationRaltegravir with Optimized Background Therapy for Resistant HIV-1 Infection
Steigbigel, R. T., Cooper, D. A., Kumar, P. N., Eron, J. E., Schechter, M., Markowitz, M., Loutfy, M. R., Lennox, J. L., Gatell, J. M., Rockstroh, J. K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708975 · Cited by 691
Self-citationIntegrase inhibitors to treat HIV/Aids
Pommier, Y., Johnson, A. A., & Marchand, C. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1660 · Cited by 688
Metadata
- Authors
- Espeseth, A. S., Felock, P., Wolfe, A., Witmer, M., Grobler, J., Anthony, N., Egbertson, M., Melamed, J. Y., Young, S., Hamill, T., Cole, J. L., & Hazuda, D. J.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Hazuda, Daria J.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2000-10-03
- Volume
- 97
- Issue
- 21
- Pages
- 11244-11249
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC17185
- OpenAlex
- W2148026374
- Cited by
- 317
- References
- 35
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 6 · 2023: 2 · 2022: 8 · 2021: 8 · 2020: 7 · 2019: 4 · 2018: 5 · 2017: 6 · 2016: 5 · 2015: 12 · 2014: 20 · 2013: 14 · 2012: 26
- FWCI
- 7.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- HIV-1 integrase, integrase inhibitors, strand transfer, long terminal repeat, 3' end processing, scintillation proximity assay, inhibitor binding site, viral integration
- MeSH terms
- Acetoacetates, Epitopes, Base Sequence, Catalysis, DNA, Viral, Pyrroles, Substrate Specificity, HIV-1, DNA Primers, HIV Integrase, HIV Integrase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase. https://app.cochat.ai/papers/10.1073/pnas.200139397
- The paper
- Espeseth, A. S., Felock, P., Wolfe, A., Witmer, M., Grobler, J., Anthony, N., Egbertson, M., Melamed, J. Y., Young, S., Hamill, T., Cole, J. L., & Hazuda, D. J. (2000). HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.200139397
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.